Interleukin-11 (IL-11) is known to be a member of the interleukin-6 (IL-6)-
type cytokine family. IL-11 is likely to be a major determinant of immune r
egulation in acute and chronic inflammatory lung diseases, although it is n
ot directly linked with specific disease processes. It has already been sho
wn that although unstimulated human lung fibroblasts did not produce signif
icant amounts of IL-11, the addition of interleukin-1 alpha (IL-1 alpha) an
d/or transforming growth factor-beta (TGF-beta) stimulated fibroblasts dose
-dependently to produce IL-11. Northern blot analysis showed that these sti
mulators also upregulated IL-11 mRNA expression. As it has been previously
reported that IL-1 and TGF-beta stimulate prostaglandin E-2 (PGE(2)) releas
e from lung fibroblasts, we investigate here the role of endogenous PGE(2)
and the direct effects of the two inhibitors of prostaglandin synthesis, in
domethacin and dexamethasone, on IL-11 production by human lung fibroblasts
. The addition of indomethacin, a cyclo-oxygenase inhibitor, resulted in si
gnificant suppression of IL-11 production and mRNA expression in lung fibro
blasts. There was no detectable effect of PGE(2) alone on IL-11 levels; how
ever, the suppression of IL-11 production by indomethacin was almost comple
tely reversed by addition of PGE(2). In contrast, suppression of IL-11 prod
uction by indomenthacin was not reversed by addition of thromboxane B-2 and
carbocyclic thromboxane A(2) In addition, dexamethasone completely suppres
sed IL-11 production and downregulated IL-11 mRNA. These results suggest th
at endogenous PGE(2) acts as an autocrine stimulus for IL-11 production by
human lung fibroblasts activated by IL-1 alpha and TCF-beta. (C) 1999 HARCO
URT PUBLISHERS LTD.